Abstract：
BACKGROUND:Breast cancer has been poorly studied in women with intellectual disability (ID), which makes designing a policy for screening the nearly 70 million women with ID in the world difficult. As no data is available in the literature, we evaluated breast cancer at diagnosis in women with ID. METHODS:Women with ID were searched retrospectively among all women treated for invasive breast cancer in a single hospital over 18 years. Age at diagnosis was compared among the whole group of women. Tumor size, lymph node involvement, SBR grade, TNM classification, and AJCC stage were compared to controls matched for age and period of diagnosis using conditional logistic regression. RESULTS:Among 484 women with invasive breast cancer, 11 had ID. The mean age at diagnosis was 55.6 years in women with ID and 62.4 years in the other women. The mean tumor size in women with ID was 3.53 cm, compared to 1.80 cm in 44 random controls from among the 473 women without ID. Lymph node involvement was observed in 9 of the 11 women with ID compared to 12 of the controls (OR = 11.53, p = 0.002), and metastases were found in 3 of the 11 women with ID compared to 1 of the 44 controls (OR = 12.00, p = 0.031). The AJCC stage was higher in women with ID compared to controls (OR = 3.19, p = 0.010). CONCLUSIONS:Women with ID presented at an earlier age with tumors of a higher AJCC stage than controls despite no significant differences in tumor grade and histological type. Thus, delayed diagnosis may be responsible for the differences between disabled and non-disabled women.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Satgé D,Sauleau EA,Jacot W,Raffi F,Azéma B,Bouyat JC,El Hage Assaf Ndoi
10.1186/1471-2407-14-150subject
Has Abstractpub_date
2014-03-04 00:00:00pages
150issn
1471-2407pii
1471-2407-14-150journal_volume
14pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combined therapy is intensified by the addition of the EGFR inhibitor cetuximab (Erbitux®). Radiation the...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/1471-2407-10-651
更新日期：2010-11-26 00:00:00
abstract：BACKGROUND:Advances in childhood cancer treatment over the past decades have significantly improved survival, resulting in a rapidly growing group of survivors. However, both chemo- and radiotherapy may adversely affect reproductive function. This paper describes the design and encountered methodological challenges of ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-363
更新日期：2012-08-23 00:00:00
abstract：BACKGROUND:This study aimed to evaluate the safety and feasibility of self-expanding metallic stent (SEMS) followed by neoadjuvant chemotherapy prior to elective surgery for obstructing left-sided colon cancer. METHODS:Eleven consecutive patients with obstructing left-sided colon cancer between May 2014 and November 2...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-6560-x
更新日期：2020-01-28 00:00:00
abstract：BACKGROUND:Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) are promising cancer drugs currently in clinical trials in oncology, including APO866, CHS-828 and the CHS-828 prodrug EB1627/GMX1777, but cancer cell resistance to these drugs has not been studied in detail. METHODS:Here, we introduce an analogue...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-677
更新日期：2010-12-12 00:00:00
abstract：BACKGROUND:The standard therapy regimen of conventional osteosarcoma includes neoadjuvant chemotherapy followed by surgical resection and postoperative chemotherapy. The percentage of necrotic tissue following induction chemotherapy is assessed by using the Huvos grading system, which classifies patients as "poor respo...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-606
更新日期：2014-08-20 00:00:00
abstract：BACKGROUND:Cervical dysplasia and tumorigenesis have been linked with numerous chromosomal aberrations. The goal of this study was to evaluate 35 genomic regions associated with cervical disease and to select those which were found to have the highest frequency of aberration for use as probes in fluorescent in-situ hyb...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-432
更新日期：2010-08-16 00:00:00
abstract：PURPOSE:Colorectal cancer (CRC) screening has been shown to decrease CRC mortality. Organised mass screening programs are being implemented in France. Its perception in the general population and by general practitioners is not well known. METHODS:Two nationwide observational telephone surveys were conducted in early ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-104
更新日期：2008-04-15 00:00:00
abstract：BACKGROUND:Short telomeres have been associated with increased risk of many cancers, particularly cancers of the gastrointestinal tract including esophagus and stomach. However, the association between telomere length (TL) and colorectal cancer and its precursors, colorectal polyps, is not clear. METHODS:We investigat...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4426-2
更新日期：2018-05-02 00:00:00
abstract：BACKGROUND:Appropriate assessment is essential for the management of chemotherapy-induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated, which is high on the list of causes of distress for cancer patients. However, objective assessment by medical staff makes it easy to underestimate ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6113-3
更新日期：2019-09-10 00:00:00
abstract：BACKGROUND:PRDM5 is an epigenetic regulator that has been recognized as an important tumour suppressor gene. Silencing of PRDM5 by promoter hypermethylation has been demonstrated in several cancer types and PRDM5 loss results in upregulation of the Wnt pathway and increased cellular proliferation. PRDM5 has not been ex...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1011-9
更新日期：2015-01-23 00:00:00
abstract：BACKGROUND:Gastric cancer is a considerable burden for worldwide patients. And diffuse gastric cancer is the most insidious subgroup with poor survival. The phenotypic characterization of the diffuse gastric cancer cell line can be useful for gastric cancer researchers. In this article, we aimed to characterize the dif...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-06814-4
更新日期：2020-04-15 00:00:00
abstract：BACKGROUND:High-dose (HD) chemotherapy followed by autologous blood stem-cell transplantation (ASCT) is the standard treatment for multiple myeloma (MM) patients. However, the collection of sufficient peripheral blood stem cell (PBSC) grafts can be challenging, and the question arises whether reinfusion of low-dose gra...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-06873-7
更新日期：2020-04-25 00:00:00
abstract：BACKGROUND:Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find out promising novel biomarkers for effective treatment. The goal of this study was to evaluate the b...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2775-2
更新日期：2016-09-30 00:00:00
abstract：BACKGROUND:Hepatocyte carcinoma (HCC) is one of the most common malignancies worldwide. Despite many achievements in diagnosis and treatment, HCC mortality remains high due to the malignant nature of the disease. Novel approaches, especially for targeted therapy, are being extensively explored. Gene therapy is ideal fo...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1339-1
更新日期：2015-04-29 00:00:00
abstract：:ABSTRACT: BACKGROUND: The aim of this study was to assess the extent of knowledge of primary health care (PHC) patients about colorectal cancer (CRC), their attitudes toward population-based screening for this disease and gender differences in these respects. METHODS: A questionnaire-based survey of PHC patients in t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-408
更新日期：2011-09-25 00:00:00
abstract：BACKGROUND:Melanoma can be lethal if not detected early and treated. Early detection can be facilitated via skin self-examination (SSE) and as such, SSE is part of melanoma follow-up care for individuals with a prior history, who face a life-long risk of reoccurrence. The objective of the current study was to identify ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6476-5
更新日期：2020-02-14 00:00:00
abstract：BACKGROUND:Ovarian cancer remains the most fatal gynecological malignancy. Current therapeutic options are limited due to late diagnosis in the majority of the cases, metastatic spread to the peritoneal cavity and the onset of chemo-resistance. Thus, novel therapeutic approaches are required. Statins and amino-bisphosp...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07164-x
更新日期：2020-07-29 00:00:00
abstract：BACKGROUND:While mathematical models are often used to predict progression of cancer and treatment outcomes, there is still uncertainty over how to best model tumor growth. Seven ordinary differential equation (ODE) models of tumor growth (exponential, Mendelsohn, logistic, linear, surface, Gompertz, and Bertalanffy) h...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2164-x
更新日期：2016-02-26 00:00:00
abstract：BACKGROUND:Excision repair cross-complementing group 2 (ERCC2) plays important roles in the repair of DNA damage and adducts. Single nucleotide polymorphisms (SNPs) of ERCC2 gene are suspected to influence the risks of oral cancer. We performed a meta-analysis to systematically summarize the possible association of ERC...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/1471-2407-13-594
更新日期：2013-12-12 00:00:00
abstract：BACKGROUND:Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is critical for the treatment of Her2-overexpressed metastatic breast cancer. METHODS:To further understand Herceptin resistance mechanisms at the molecular level, we used comparative proteome approaches to analyze two human ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-286
更新日期：2008-10-04 00:00:00
abstract：BACKGROUND:Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic activity across human cancers, including breast cancer. METHODS:To clarify this dichotomous role in bre...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5839-2
更新日期：2019-06-28 00:00:00
abstract：BACKGROUND:The incidence of Cholangiocellular Carcinoma (CCA) is increasing in the western world. The tumour has a high proportion of desmoplastic stroma and is correlated with a worse prognosis when cancer associated myofibroblasts (CAFs) are present. Recent studies showed promising results after liver transplantation...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2360-8
更新日期：2016-05-20 00:00:00
abstract：BACKGROUND:Ovarian cancer (OV) is one of the most common malignant tumors of gynecology oncology. The lack of effective early diagnosis methods and treatment strategies result in a low five-year survival rate. Also, immunotherapy plays an important auxiliary role in the treatment of advanced OV patient, so it is of gre...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07695-3
更新日期：2020-12-07 00:00:00
abstract：BACKGROUND:It is well established that genetic and epigenetic alterations are common events in prostate cancer, which may lead to aberrant expression of critical genes. The importance of epigenetic mechanisms in prostate cancer carcinogenesis is increasingly evident. In this study, the focus will be on histone modifica...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-994
更新日期：2014-12-23 00:00:00
abstract：BACKGROUND:Although this effect is well known, tailored treatment methods have not yet been broadly adopted. The aim of this study was to identify those patient characteristics that most influence the impairment of quality of life and thus to identify those patients who need and can benefit most from specific intervent...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2822-z
更新日期：2016-10-10 00:00:00
abstract：BACKGROUND:An understanding of growth dynamics of tumors is important in understanding progression of cancer and designing appropriate treatment strategies. We perform a comparative study of the hyperbolastic growth models with the Weibull and Gompertz models, which are prevalently used in the field of tumor growth. M...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-509
更新日期：2010-09-23 00:00:00
abstract：BACKGROUND:In a phase I study of angiotensin-(1-7) [Ang-(1-7)], clinical benefit was associated with reduction in plasma placental growth factor (PlGF) concentrations. The current study examines Ang-(1-7) induced changes in biomarkers according to cancer type and investigates mechanisms of action engaged in vitro. MET...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-404
更新日期：2012-09-11 00:00:00
abstract：BACKGROUND:Prostate cancer is the second leading cause of male cancer death in developed countries. Although the role of angiogenesis in its progression is well established, the efficacy of anti-angiogenic therapy is not clearly proved. Whether this could depend on differential responses between tumor and normal endoth...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-939
更新日期：2014-12-12 00:00:00
abstract：BACKGROUND:Vinflunine is recommended in the European guideline for the treatment of advanced or metastatic urothelial cell carcinoma (UCC) after failure of platinum-based therapy. METHODS:This prospective, non-interventional study investigated the safety and efficacy of vinflunine in platinum-pretreated UCC patients i...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/s12885-015-1434-3
更新日期：2015-06-04 00:00:00
abstract：BACKGROUND:The incidence of breast cancer among young women (aged ≤40 years) has increased in North America and Europe. Fewer than 10% of cases among young women are attributable to inherited BRCA1 or BRCA2 mutations, suggesting an important role for somatic mutations. This study investigated genomic differences betwee...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-6684-z
更新日期：2020-03-12 00:00:00
